Welcome to our dedicated page for Donaldson news (Ticker: DCI), a resource for investors and traders seeking the latest updates and insights on Donaldson stock.
Donaldson Company, Inc. (NYSE: DCI) is a global manufacturer of technology-led filtration products and solutions, with operations organized into Mobile Solutions, Industrial Solutions and Life Sciences segments. This news page aggregates coverage related to Donaldson’s business performance, corporate actions and participation in key industrial and life sciences events.
Investors and industry followers can use this page to review earnings announcements, such as Donaldson’s reports of record quarterly and full-year sales and earnings, and updates on segment performance across Mobile, Industrial and Life Sciences. Company releases discuss factors like pricing, volume, foreign currency translation, tariff impacts, cost optimization initiatives and guidance for sales, operating margin and earnings.
News items also include capital allocation and dividend updates. Donaldson reports on quarterly cash dividend declarations and notes its membership in the S&P High-Yield Dividend Aristocrats Index, with a long record of consecutive annual dividend increases and quarterly dividend payments. Disclosures on share repurchases and cash flow provide additional context on how the company returns capital to shareholders while funding investments in its operations.
Corporate governance and investor relations activities are another focus of Donaldson’s news. Releases cover the annual meeting of stockholders, director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm. The company also announces participation in investor conferences and webcasts of its earnings conference calls, giving insight into how management communicates with the market.
In addition, Donaldson-related news can highlight developments in its Life Sciences segment, including the role of Isolere Bio by Donaldson in biopharmaceutical purification technologies and collaborations where Isolere Bio participates as a partner. Readers who follow DCI news can track how the company positions its filtration technologies across mobile, industrial and life sciences markets over time.
Donaldson Company (NYSE: DCI) has expanded its iCue™ Connected Filtration Service, enabling remote monitoring of customer dust collectors by product specialists. This service enhances operational insights through a web-based dashboard, reducing unplanned downtime and supporting efficient maintenance. The new iCue Monitor Service allows specialists to respond quickly to alerts from dust collectors, offering recommendations for maintenance or urgent solutions. This innovative approach combines advanced connectivity with over a century of industry experience, promising improved response times and operational efficiency for clients.
Donaldson Company, Inc. (NYSE: DCI) announced new leadership appointments as part of a major organizational redesign aimed at enhancing its service to end market customers. Effective November 1, 2022, the company will shift away from a matrixed structure to establish a more streamlined approach. Key appointments include Guillermo Briseño as president of Industrial Solutions and Andrew C. Dahlgren as president of Life Sciences. The redesign aims to align business models and resources with market needs while ensuring accountability for performance.
Donaldson Company (NYSE: DCI) announced that Tod Carpenter, the company's chairman, president, and CEO, will present at the Morgan Stanley 10th Annual Laguna Conference on September 15 at 2:00 p.m. PST. Investors and stakeholders can listen to the live webcast on the Investor Relations website. A replay will be available for about 90 days post-event. Founded in 1915, Donaldson remains a global leader in filtration technologies across various industries.
Donaldson Company reported a strong performance in fiscal 2022 with a 15.1% increase in fourth-quarter sales, totaling $890 million. Full-year sales rose 15.9%, achieving over $3 billion in sales. GAAP EPS was $0.81 for Q4 and $2.66 for the year, reflecting growth from fiscal 2021. The company projects fiscal 2023 sales growth of 1% to 5% and EPS between $2.91 and $3.07. Challenges from currency translation and geopolitical issues were acknowledged, alongside a positive outlook for demand and pricing stability.
Donaldson Company (NYSE: DCI) announced that its chairman and CEO, Tod Carpenter, will present at the Jefferies Industrials Conference on Tuesday, August 9, at 11:30 a.m. EDT. A live webcast of the presentation will be accessible via Donaldson's Investor Relations website, specifically under the 'Events & Presentations' section. Following the event, a replay of the webcast will be available for approximately 90 days. Donaldson is renowned for its advanced filtration solutions, serving diverse industries worldwide.
Donaldson Company, Inc. (NYSE: DCI) will host its fourth quarter and full-year fiscal 2022 earnings conference call on August 31, 2022, at 9:00 a.m. CDT. The live webcast can be accessed through the “Events & Presentations” section of Donaldson’s Investor Relations website.
A replay of the webcast will be available after 12:00 p.m. CDT on the same day.
Donaldson Company announced a regular cash dividend of 23.0 cents per share, payable on August 31, 2022, to shareholders of record on August 16, 2022. This marks Donaldson's 26th consecutive year of increasing annual dividends and maintains its position as a member of the S&P High-Yield Dividend Aristocrats Index. The company has paid cash dividends every quarter for 66 years, showcasing its commitment to returning income to shareholders.
Donaldson Company, Inc. (NYSE: DCI) has acquired Purilogics, LLC, a biotech firm specializing in membrane chromatography products, for an initial price of approximately $20 million plus potential earnout payments. This acquisition enhances Donaldson's life sciences portfolio, enabling faster and more efficient drug development and production. Purilogics' innovative technology offers significant competitive advantages in purifying biologics, including mRNA and monoclonal antibodies. The revenue from Purilogics will be integrated into Donaldson's Industrial Filtration Solutions segment.
Donaldson Company, a leading provider of filtration products and solutions, announced that Scott Robinson, CFO, will present at the Stifel 2022 Cross Sector Insight Conference on June 7 at 8:35 a.m. EDT. The event will provide insights into the company’s innovative filtration technologies. Interested participants can listen to the live webcast by visiting Donaldson’s Investor Relations website and clicking on the ‘listen to webcast’ option. A replay will be available for 90 days post-event.
Donaldson Company reported a record third-quarter 2022 sales of $853.2 million, up 11.5% from last year, despite a 1.8% decline in net earnings to $83.0 million. GAAP EPS rose slightly to $0.67. The company improved its fiscal 2022 sales guidance, now expecting a 14.5% to 16.5% increase. Despite strong demand, challenges such as inflation and supply chain constraints persist, impacting gross margin, which decreased to 31.5%. The company anticipates a slight decline in gross margins and operating margins for the full fiscal year.